Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment
Open Access
- 12 September 2024
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-17
Abstract
The tumor microenvironment (TME) exerts profound effects on tumor progression and therapeutic efficacy. In hepatocellular carcinoma (HCC), the TME is enriched with cancer-associated fibroblasts (CAFs), which secrete a plethora of cytokines, chemokines, and growth factors that facilitate tumor cell proliferation and invasion. However, the intricate architecture of the TME in HCC, as well as the mechanisms driving interactions between tumor cells and CAFs, remains largely enigmatic. We analyzed 10 spatial transcriptomics and 12 single-cell transcriptomics samples sourced from public databases, complemented by 20 tumor tissue samples from liver cancer patients obtained in a clinical setting. Our findings reveal that tumor cells exhibiting high levels of SPP1 are preferentially localized adjacent to hepatic stellate cells (HSCs). The SPP1 secreted by these tumor cells interacts with the CD44 receptor on HSCs, thereby activating the PI3K/AKT signaling pathway, which promotes the differentiation of HSCs into CAFs. Notably, blockade of the CD44 receptor effectively abrogates this interaction. Furthermore, in vivo studies demonstrate that silencing SPP1 expression in tumor cells significantly impairs HSC differentiation into CAFs, leading to a reduction in tumor volume and collagen deposition within the tumor stroma. This study delineates the SPP1-CD44 signaling axis as a pivotal mechanism underpinning the interaction between tumor cells and CAFs. Targeting this pathway holds potential to mitigate liver fibrosis and offers novel therapeutic perspectives for liver cancer management.Keywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (82372194)
This publication has 49 references indexed in Scilit:
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular CarcinomaCancer Discovery, 2019
- Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMPJournal of Experimental & Clinical Cancer Research, 2019
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast CancerCancer Cell, 2018
- The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver CancerAnnual Review of Pathology: Mechanisms of Disease, 2017
- Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cellsOncogene, 2016
- The biology and function of fibroblasts in cancerNature Reviews Cancer, 2016
- Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessNature Communications, 2016
- Synthetic approaches to the 2011 new drugsBioorganic & Medicinal Chemistry, 2013
- Glutamic Acid and Its Derivatives: Candidates for Rational Design of Anticancer DrugsFuture Medicinal Chemistry, 2013
- A modified version of Moran's IInternational Journal of Health Geographics, 2010